Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halabi

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|July 18, 2013
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairmentS Macha, M Mattheus, A Halabi, et al.
British Journal of Clinical Pharmacology|September 26, 2015
The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's diseaseL Rabinovich-Guilatt, K E Siegler, A Schultz, et al.
ACS Chemical Biology|April 17, 2020
Dual-Activatable Cell Tracker for Controlled and Prolonged Single-Cell LabelingElias A Halabi, Jorge Arasa, Salome Püntener, et al.
European Journal of Clinical Investigation|October 1, 1992
Modulation of lymphocyte subsets due to psychological stress in patients with rheumatoid arthritisS Palm, H Hinrichsen, J Barth, et al.
ACS Nano|October 12, 2023
Highly Active Myeloid Therapy for CancerIna R Fredrich, Elias A Halabi, Rainer H Kohler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 24, 2022
In Vivo Click Chemistry Enables Multiplexed Intravital MicroscopyJina Ko, Kilean Lucas, Rainer Kohler, et al.
Diabetes, Obesity & Metabolism|June 16, 2011
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)U Graefe-Mody, C Friedrich, A Port, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 6, 1998
Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levelsM Stucki, J Schnorf, H Hustinx, et al.
Theranostics|May 22, 2024
A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulationHyung Shik Kim, Elias A Halabi, Noah Enbergs, et al.
Clinical Medicine Insights. Case Reports|January 31, 2022
Infantile Parotid Hemangioma With Diagnostic Dilemma: A Case ReportKamel T Abidi, Naglaa M Kamal, Khaled A Althobaiti, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|July 18, 2013
Pharmacokinetics, pharmacodynamics and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in subjects with renal impairmentS Macha, M Mattheus, A Halabi, et al.
British Journal of Clinical Pharmacology|September 26, 2015
The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's diseaseL Rabinovich-Guilatt, K E Siegler, A Schultz, et al.
ACS Chemical Biology|April 17, 2020
Dual-Activatable Cell Tracker for Controlled and Prolonged Single-Cell LabelingElias A Halabi, Jorge Arasa, Salome Püntener, et al.
European Journal of Clinical Investigation|October 1, 1992
Modulation of lymphocyte subsets due to psychological stress in patients with rheumatoid arthritisS Palm, H Hinrichsen, J Barth, et al.
ACS Nano|October 12, 2023
Highly Active Myeloid Therapy for CancerIna R Fredrich, Elias A Halabi, Rainer H Kohler, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 24, 2022
In Vivo Click Chemistry Enables Multiplexed Intravital MicroscopyJina Ko, Kilean Lucas, Rainer Kohler, et al.
Diabetes, Obesity & Metabolism|June 16, 2011
Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)U Graefe-Mody, C Friedrich, A Port, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|August 6, 1998
Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levelsM Stucki, J Schnorf, H Hustinx, et al.
Theranostics|May 22, 2024
A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulationHyung Shik Kim, Elias A Halabi, Noah Enbergs, et al.
Clinical Medicine Insights. Case Reports|January 31, 2022
Infantile Parotid Hemangioma With Diagnostic Dilemma: A Case ReportKamel T Abidi, Naglaa M Kamal, Khaled A Althobaiti, et al.
Pageof 7